Literature DB >> 23632260

Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study.

Imad R Makhoul, Ofra Peleg, Benjamin Miller, Benjamin Bar-Oz, Orna Kochavi, Hadas Mechoulam, Eedy Mezer, Irena Ulanovsky, Tatiana Smolkin, Claudia Yahalom, Asaad Khoury, Avraham Lorber, Amiram Nir, Shraga Blazer.   

Abstract

Entities:  

Keywords:  Neonatology; Ophthalmology

Mesh：

Substances：

Year:  2013        PMID： 23632260     DOI： 10.1136/archdischild-2013-303951

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  14 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  Blood flow assessed by color Doppler imaging in retinopathy of prematurity.

Authors:  S Hartenstein; B Müller; B Metze; C Czernik; C Bührer
Journal:  J Perinatol       Date:  2015-05-07       Impact factor: 2.521

3.  Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial.

Authors:  Luca Filippi; Giacomo Cavallaro; Paola Bagnoli; Massimo Dal Monte; Patrizio Fiorini; Elettra Berti; Letizia Padrini; Gianpaolo Donzelli; Gabriella Araimo; Gloria Cristofori; Monica Fumagalli; Giancarlo la Marca; Maria Luisa Della Bona; Roberta Pasqualetti; Pina Fortunato; Silvia Osnaghi; Barbara Tomasini; Maurizio Vanni; Anna Maria Calvani; Silvano Milani; Ivan Cortinovis; Alessandra Pugi; Massimo Agosti; Fabio Mosca
Journal:  Pediatr Res       Date:  2016-11-04       Impact factor: 3.756

4.  The Role of Catecholamines in the Development of Pathological Retina Neovascularization in an Experimental Model of Retinopathy of Prematurity in Rats.

Authors:  L A Katargina; N A Osipova; A Y Panova; A V Petrovskaya; Y O Nikishina; A R Murtazina; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2020-03-04       Impact factor: 0.788

Review 5.  Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.

Authors:  Siree Kaempfen; Roland P Neumann; Kerstin Jost; Sven M Schulzke
Journal:  Cochrane Database Syst Rev       Date:  2018-03-02

6.  Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.

Authors:  Luca Filippi; Giacomo Cavallaro; Elettra Berti; Letizia Padrini; Gabriella Araimo; Giulia Regiroli; Valentina Bozzetti; Chiara De Angelis; Paolo Tagliabue; Barbara Tomasini; Giuseppe Buonocore; Massimo Agosti; Angela Bossi; Gaetano Chirico; Salvatore Aversa; Roberta Pasqualetti; Pina Fortunato; Silvia Osnaghi; Barbara Cavallotti; Maurizio Vanni; Giulia Borsari; Simone Donati; Giuseppe Nascimbeni; Giancarlo la Marca; Giulia Forni; Silvano Milani; Ivan Cortinovis; Paola Bagnoli; Massimo Dal Monte; Anna Maria Calvani; Alessandra Pugi; Eduardo Villamor; Gianpaolo Donzelli; Fabio Mosca
Journal:  BMC Pediatr       Date:  2017-07-14       Impact factor: 2.125

7.  Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial.

Authors:  Christoph Bührer; Ömer Erdeve; Dirk Bassler; Benjamin Bar-Oz
Journal:  BMJ Open       Date:  2018-07-06       Impact factor: 2.692

8.  Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.

Authors:  Lara Carroll; Leah A Owen
Journal:  Explor Med       Date:  2020-02-29

9.  The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy.

Authors:  Maurizio Cammalleri; Filippo Locri; Elisabetta Catalani; Luca Filippi; Davide Cervia; Massimo Dal Monte; Paola Bagnoli
Journal:  Front Cell Neurosci       Date:  2017-12-12       Impact factor: 5.505

10.  Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study.

Authors:  Luca Filippi; Giacomo Cavallaro; Lavinia Perciasepe; Elena Sandini; Gabriella Araimo; Giulia Regiroli; Genny Raffaeli; Paola Bagnoli; Massimo Dal Monte; Maura Calvani; Pina Fortunato; Silvia Osnaghi; Salvatore De Masi; Fabio Mosca
Journal:  Front Pediatr       Date:  2019-11-13       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.